Integra Lifesciences Holdings Corporation · NASDAQ:IART

Integra Lifesciences — Corporate Update (April 2015)

7 slides from Integra Lifesciences's corporate update, Apr 13, 2015

  1. Slide 1: Historical Segment Revenue: New Segments 2012 – 2014

    Exhibit 99.1 Historical Segment Revenue: New Segments 2012 – 2014

  2. Slide 2: New Reporting Segments Information

    New Reporting Segments Information In November 2014, Integra announced the strategic decision to spin off the orthobiologics and spinal fusion hardware business into a separate, publicly traded company called SeaSpine Holdings Corporation. Integra management believes that a stand-alone SeaSpine will

  3. Slide 3: Annual Revenue: 2012 – 2014

    Annual Revenue: 2012 – 2014 UNAUDITED ($ in Thousands) Global Segment Revenues: In thousands 2012 2013 2014 Specialty Surgical Solutions $ 464,169 $ 463,296 $ 554,872 U.S. 334,168 332,781 399,538 International 130,001 130,515 155,334 Orthopedics & Tissue Technologies 218,972 225,737 235,539 U.S. 174

  4. Slide 4: Quarterly Revenue: 2013

    Quarterly Revenue: 2013 UNAUDITED ($ in Thousands) Global Segment Revenues: In thousands Q1 13 Q2 13 Q3 13 Q4 13 2013 Specialty Surgical Solutions $ 106,433 $ 114,598 $ 120,780 $ 121,485 $ 463,296 U.S. 76,161 81,905 87,383 87,332 332,781 International 30,272 32,693 33,397 34,153 130,515 Orthopedics

  5. Slide 5: Quarterly Revenue: 2014

    Quarterly Revenue: 2014 UNAUDITED ($ in Thousands) Global Segment Revenues: In thousands Q1 14 Q2 14 Q3 14 Q4 14 2014 Specialty Surgical Solutions $ 127,195 $ 137,516 $ 137,499 $ 152,662 $ 554,872 U.S. 90,447 99,379 101,403 108,309 399,538 International 36,748 38,137 36,096 44,353 155,334 Orthopedic

  6. Slide 6: Integra Historic Revenue Reporting Segments

    Integra Historic Revenue Reporting Segments Integra Prior Segments (% of Total 2014 Revenue) U.S. U.S. Spine & U.S. Instruments International U.S. Extremities Neurosurgery Other (17%) (23%) (15%) (26%) (19%) (%) Shows percentages of 2014 Revenues 6

  7. Slide 7: Integra New Revenue Reporting Segments

    Integra New Revenue Reporting Segments U.S. Neurosurgery U.S. Instruments International U.S. Extremities U.S. Spine & Other (26%) (17%) (23%) (15%) (19%) Specialty Surgical Orthopedics & Tissue Solutions Technologies (60%) (25%) Spine (15%) Key Franchises: Key Franchises: Dural Repair Regenerative P

Integra LifeSciences Holdings — Corporate Update (April 2015) on 6ix